Jones Jeffrey Alan
SEC Form 4 insider trading activity
Jones Jeffrey Alan has filed 6 SEC Form 4 filings (6 transaction rows) across 2 companies, including WSR, CGEM, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Jul 15, 2026.
On the most recent filing, Jones Jeffrey Alan is listed as Chief Medical Officer at Cullinan Therapeutics, Inc. Inside the rolling window, Jones Jeffrey Alan reported no open-market purchases and 3 open-market sales totaling $179K in CGEM. The largest disclosed transaction in the window is a sale of 4,982 CGEM shares on Feb 20, 2026, worth $68K.
Companies traded
Other insiders at WSR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$179K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Jones Jeffrey Alan made?
Jones Jeffrey Alan has filed 6 SEC Form 4 filings (6 transaction rows) across 2 companies, including WSR, CGEM since 2025.
Which companies does Jones Jeffrey Alan trade?
Jones Jeffrey Alan has filed SEC Form 4 disclosures for 2 companies, including WSR, CGEM.
When was Jones Jeffrey Alan's most recent SEC Form 4 filing?
Jones Jeffrey Alan's most recent SEC Form 4 filing on Tracefour is dated Jul 15, 2026.
What is Jones Jeffrey Alan's total buy and sell value in the current window?
Inside the rolling retention window, Jones Jeffrey Alan bought $0 and sold $179K based on SEC Form 4 filings.
What was Jones Jeffrey Alan's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 4,982 CGEM shares on 2026-02-20, worth $68K, per SEC Form 4 filings.